• MPO/PR-3 (ANCA) Antibodies
  • Mycoplasma pneumoniae, Culture
  • Protein Immunofixation Electrophoresis, CSF
  • Retinoic Acid Receptor Gamma (RARG) Genotyping
  • Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) Genotyping
  • Adrenal hyperplasia
  • Lymphedema
  • Lysozyme (Muramidase), Serum
  • Glycogen storage disease type II (Pompe disease)
  • Carboxy-Tetrahydrocannabinol (THC) Metabolite, Serum or Plasma, Quantitative
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Maple Syrup Disease Testing
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Maple Syrup Disease Testing
Medical Test

Additional Testing
Access to Maple Syrup Disease Testing is restricted.
Loading...